Story

WuXi XDC Shares Fall on Major Shareholder's Planned Stake Sale

ENTHMSVIIDZHZH-TWJAKOHI
Aug 27, 20261 min read
WuXi XDC Shares Fall on Major Shareholder's Planned Stake Sale
Text size
Background

Shares of WuXi XDC Cayman (2268.HK) fell on Thursday, pressured by reports that a major shareholder is planning to sell a portion of its stake to raise capital. The decline reversed some of the stock's recent gains, which were driven by strong earnings results earlier in the week.

Shareholder Stake Sale

According to Chinese media reports, STA Pharmaceutical Hong Kong, a key shareholder in WuXi XDC, placed 53.5 million shares for sale. The placement price was set at HK$73.23 per share, representing a notable discount to the stock's closing price on Wednesday.

The sale is reportedly intended to raise as much as $500 million. Large stake sales, particularly at a discount to the market price, can create downward pressure on a stock as the market absorbs the increased supply of shares.

Sample IUX Markets – In-articleAd

Market Reaction and Context

In Thursday's trading, WuXi XDC's stock slid 2.6% to close at HK$75.25. The move underperformed the broader Hong Kong market, which posted gains for the day.

The sell-off also appears to be linked to profit-taking. The stock had rallied sharply earlier in the week following the release of a strong first-half earnings report, and the news of the share placement provided a catalyst for investors to lock in recent profits.

Read next

More on Stocks
Back to latest news

LATEST